Michael Narachi, President and CEO at Orexigen Therapeutics, Inc. (OREX), bought 50,000 shares at $4.78 ($239K) on 2014-09-15, disclosed to the SEC on 2014-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OREX | SELL | 2012-07-13 | $1.0M | — | Filing → |
| OREX | SELL | 2012-06-29 | $1.3M | — | Filing → |
| AMAG | BUY | 2012-05-29 | $27K | — | Filing → |